News from Prime
Integrated medical and pharmacy claims data is essential in developing cost management strategies.
Centers for Medicare & Medicaid Services tracks use of high-risk medications as Star metric.
Prime analyzed members’ use of rheumatoid arthritis (RA) drug tofacitinib (Xeljanz®) to find patterns and adherence behaviors.
Prime in the news
Drug Channels | September 7, 2016
Specialty Pharmacy Times | September 1, 2016
Star Tribune | August 29, 2016
Minneapolis/St. Paul Business Journal | August 29, 2016